Important Notice
This Inari Medical website and all product offerings listed are tailored for the United States only. Please be aware that product availability and regulatory claims may vary in other regions we serve, including Europe, the Middle East, and Africa (EMEA), Asia-Pacific (APAC), and Latin America/Canada. Inari Medical is currently developing separate websites for our products tailored to these other global and regional markets.
“The success of our VTE Excellence™ program has been driven by a robust, systematic process for identifying patients who can benefit from intervention.”
—Michael Knox, MD, FACR
Interventional Radiologist
Advanced Radiology Services – Grand Rapids
Spectrum Health Hospitals
STRATEGIC APPROACH TO PROGRAM
DEVELOPMENT
Inari Medical is pioneering the treatment of venous disease through long-term, strategic partnerships through the Inari Solutions Group (ISG). ISG partners with health systems and physicians to improve patient pathways, clinical outcomes, health economics and disease awareness.
Patient Pathway
Customized processes to appropriately identify and treat patients that improve:
- Triage
- Treatment
- Follow-up
Clinical Outcomes
Access to purpose-built medical devices and training support designed to improve:
- Mortality
- Resource utilization
- Readmission and LOS
Health Economics
Comprehensive support to provide tailored assistance with:
- Resource efficiencies
- Reimbursement
- Coding and billing support
Disease Awareness
Tools to expand understanding of disease and advanced therapy options, including:
- Media
- Patient testimonials
- Inreach and outreach
References:
1. Centers for Disease Control and Prevention. Venous Thromboembolism (Blood Clots). Data & Statistics.
2. Secemsky E et al. High Burden of 30-Day Readmissions After Acute Venous Thromboembolism in the United States. Journal of American Heart Association. 2018.
3. Lacey MJ et al. Prospective Experience of Pulmonary Embolism Management and Outcomes. J Invasive Cardiol. 2021.
4. Key N et al. Current Treatment of Venous Thromboembolism. Arterioscler Thromb Vasc Biol. March 2010.
5. Rokosh R et al. High Incidence of patients lost to follow-up after venous thromboembolism diagnosis— Identifying an unmet need for targeted transition of care. Vascular. 2021.